RA Capital Management »

Compass Pathways shares owned by RA Capital Management

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by RA Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 1.3M 8.75
2023-09-30 $9.5M 1.3M 7.40

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Immunogen SH
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Aerovate Therapeutics SH (AVTE)
Inhibrx SH (INBX)
Cymabay Therapeutics SH
Biogen SH (BIIB)
Rxsight SH (RXST)
89bio SH (ETNB)
Verona Pharma Plc - SH (VRNA)
Day One Biopharmaceuticals I SH (DAWN)
An2 Therapeutics SH (ANTX)
Tyra Biosciences SH (TYRA)

View all positions for RA Capital Management

Top funds holding Compass Pathways

Paradigm Biocapital Advisors
ARK Investment Management
Citadel Advisors
Vivo Capital
RA Capital Management
Soleus Capital Management
Aisling Capital Management
Rosalind Advisors
Laurion Capital Management
Barclays
Logos Global Management
Alyeska Investment Group
Nikko Asset Management Americas
Partner Fund Management
Sumitomo Mitsui Trust Holdings

View all funds holding Compass Pathways